Clinical Trial: Pioglitazone for Oral Premalignant Lesions

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: Phase IIB Randomized, Placebo Controlled Trial of Pioglitazone for Oral Premalignant Lesions an Inter-consortium Collaborative Study

Brief Summary: The goal of this clinical research study is to learn how Actos (pioglitazone) may affect oral premalignant lesions (OPLs) and/or the risk of mouth cancer. The safety of this drug will also be studied.